Marisa Altamirano
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Integra Lifesciences Corporation at 28.9% of the total. Reporting peaked in 2022 at $957 and has fallen 55.7% since, to $424 in 2025.
Across 65 payments — averaging $35.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$674
- AstraZeneca$333
- GSK$306
- Kerecis Limited$267
- Sanofi$192
- Philips North America LLC$82
- plus $477 from 15 others
What the payments were for
- Food & beverage$2,26997%
- Education$613%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 7 | $674 |
| AstraZeneca | 5 | $333 |
| GSK | 14 | $306 |
| Kerecis Limited | 2 | $267 |
| Sanofi | 7 | $192 |
| Philips North America LLC | 5 | $82 |
| Boehringer Ingelheim | 5 | $74 |
| Smith+Nephew | 1 | $63 |
| Sanofi-aventis U.S. LLC | 1 | $58 |
| Mylan Specialty L.p. | 3 | $48 |
| Acera Surgical, Inc. | 1 | $34 |
| Solventum Corporation | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Amgen | 2 | $25 |
| Regeneron Healthcare Solutions, Inc. | 2 | $25 |
| Convatec Inc. | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| KCI USA, Inc. | 1 | $14 |
| Merck | 1 | $12 |
| United Therapeutics Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$1,892
- Kerecis Omega3 Marigen$692
- INTEGRA DERMAL REGENERATION TEMPLATE$631
- PRIMATRIX$631
- Kerecis Omega3 SurgiClose$519
- Kerecis Omega3 GraftGuide$126
- BREZTRI$125
- TRELEGY ELLIPTA$125
- TEZSPIRE$110
- DUPIXENT$103
How this compares
$2,330 in reported general payments places this provider in the 85th percentile of 462 surgical providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $4,156 |
| Donepezil Hcl | 14 | $435 |
| Cephalexin | 28 | $202 |
Paid to pharmacies, not to this prescriber.
Other surgical in Union
- Dean BaroneUnion$69K
- Matthew PetridesNeptune$183K
- Andrea ConwayCherry Hill$105K
- Jessica HendersonEatontown$53K
- Richard BengelCamden$44K
- Dylan RyanCamden$26K
- Lauren RoyceClifton$11K
- Rachel WintMount Laurel$10K
- Richard HulseNeptune$10K
- Mimi OliffWest Orange$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.